Size, structure help poziotinib pose threat to deadly exon 20 lung cancer

Posted on

Source: University of Texas M. D. Anderson Cancer Center

Summary: A drug that failed to effectively strike larger targets in lung cancer hits a bulls-eye on the smaller target presented by a previously untreatable form of the disease.

To know more: https://www.scitechnol.com/clinical-experimental-oncology.php

Contact us by E-mail: editor.jceog@scitechnol.com or Online Submissison

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s